Press Releases

EQRX’S MARKETING AUTHORIZATION APPLICATION FOR AUMOLERTINIB IN EGFR-MUTATED NON-SMALL CELL LUNG CANCER ACCEPTED BY THE EUROPEAN MEDICINES AGENCY (EMA)

2022 ESMO ASIA | Hansoh Pharma's Ameile Fills Data Gaps with Eight More Innovations

Hansoh Pharma Announced Strategic Collaboration with Biotheus on Co-Development of EGFR/cMet Bispecific Antibody Drug

Hansoh Pharma Named to HRoot's "Best Employers in Greater China 2022" List

With Significant Improvement in S&P Global CSA Score, Hansoh Pharma Receives International Recognition for ESG Sustainability

Hansoh Pharma announced strategic partnership with KiOmed Pharma of Belgium to co-develop a new-generation innovative product for the treatment of osteoarthritis

Technology Fuels a Sustainable Future|Hansoh Pharma's Production Facility Achieves Full Certification in Energy and Environmental Management Standards

Hansoh Pharma Ranked Among 2022 Top 100 Chinese Pharmaceutical Innovative Companies and China's Top 5 Pharmaceutical Innovation and Upgrading Role Models